PMID: 42336230

Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation.

Fazal Owais, Loya Asad, Muayad Jawad, Alsoudi Amer F, Bordbar Darius D, Chaaya Celine, Weng Christina Y, Rahimy Ehsan, Patel Nimesh A

American journal of ophthalmology · 2026

Vol. 290, pp. 246-251

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.